BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24776385)

  • 1. [Liquid-based cervical cytology ThinPrep screening in Hungary].
    Bak M; Séberné Éll M; Bóka M; Veleczki Z; Nyári T; Pete I; Szentirmay Z
    Orv Hetil; 2014 May; 155(18):708-14. PubMed ID: 24776385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
    Hutchinson ML; Zahniser DJ; Sherman ME; Herrero R; Alfaro M; Bratti MC; Hildesheim A; Lorincz AT; Greenberg MD; Morales J; Schiffman M
    Cancer; 1999 Apr; 87(2):48-55. PubMed ID: 10227593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?
    Baer A; Kiviat NB; Kulasingam S; Mao C; Kuypers J; Koutsky LA
    Obstet Gynecol; 2002 Jun; 99(6):1053-9. PubMed ID: 12052599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.
    Lörincz AT; Richart RM
    Arch Pathol Lab Med; 2003 Aug; 127(8):959-68. PubMed ID: 12873167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
    Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
    Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program.
    Davey DD; Souers RJ; Goodrich K; Mody DR; Tabbara SO; Booth CN
    Arch Pathol Lab Med; 2019 Oct; 143(10):1196-1202. PubMed ID: 31021657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: A multicentric international study.
    Kholová I; Negri G; Nasioutziki M; Ventura L; Capitanio A; Bongiovanni M; Cross PA; Bourgain C; Edvardsson H; Granados R; Lipiński A; Obermann EC; Pinamonti M; Sidlova H; Strojan Fležar M; van Kemenade FJ; Vrdoljak-Mozetic D; Fassina A; Cochand-Priollet B
    Cancer Cytopathol; 2022 Dec; 130(12):939-948. PubMed ID: 35833701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology.
    Gonzalez-Bosquet E; Almagro MM; Mora I; Suñol M; Callejo J; Lailla JM
    Eur J Gynaecol Oncol; 2006; 27(2):135-8. PubMed ID: 16620054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.